UBE3A and cervical carcinoma: MiR-375 was found to be the target of Ubiquitin-protein ligase E3A (UBE3A) in cervical cancer[59,60], and the improvement of radio sensitivity in HR-HPV (+) cervical cancer is highly correlated with miR-375-UBE3A axis.